A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1010 in Healthy Children
NCT07870330
This study is recruiting at 6 US sites in 6 states, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of this study is to evaluate safety, reactogenicity, and immunogenicity of mRNA-1010 in healthy children (9 to <18 years of age).
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Seasonal Influenza
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 1
- Ages
- 9 to 17 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- ModernaTX, Inc.
- Last updated on ClinicalTrials.gov
- November 5, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 1
- Paradigm Clinical Research Centers, LLC · Modesto, CA
Colorado · 1
- Paradigm Clinical Research Centers, LLC · Aurora, CO
Minnesota · 1
- Clinical Research Institute, Inc · Minneapolis, MN
Ohio · 1
- Senders Pediatrics · South Euclid, OH
Texas · 1
- West Houston Clinical Research Service · Houston, TX
Virginia · 1
- Clinical Research Partners, LLC. · Richmond, VA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.